FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Pneumococcal Testing Market Overview:

According to FutureWise analysis the market for pneumococcal testing in 2023 is US$ 1.78 billion, and is expected to reach US$ 4.23 billion by 2031 at a CAGR of 11.4%.

There has been a substantial rise in the number of pneumococcal testing across the world with the current COVID-19 pandemic. Rising emphasis on molecular diagnostics for detecting respiratory pathogens has resulted in the pneumococcal testing market growth to a substantial level. Furthermore, this testing has gained clinical importance with respect to the ability of demonstrating high analytical specificity and sensitivity along with the capability of processing multiple respiratory specimens. The point of care testing is generally preferred as the conventional testing technique. This can be credited to the increased necessity to offer real-time results that aid the physicians to make correct decisions in the disease treatment. Furthermore, these tests are used for medical care has shifted focus on early detection, prevention and managing chronic conditions.

Major Players included in the Pneumococcal Testing Market:

Thermo Fisher Scientific Inc.
Abbott Laboratories
F-Hoffmann la Roche Ltd.
Hologic Inc.
bioMerieux
Becton Dickenson and Company
Bio-Rad Laboratories Inc.
Meridian Biosciences
Quest Diagnostics
Quidel

(Note: The list of the major players will be updated with the latest market scenario and trends)

Pneumococcal Testing Market Segmentation:

By Method

Immunodiagnostics
Molecular Diagnostics
Point of Care Testing

By Technology

Enzyme Linked Immunosorbent Assay
Immunofluorescence
Western Blot
Polymerase Chain Reaction
Immunohistochemistry
Others

By End User

Hospitals
Homecare
Diagnostic Laboratories
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The market is categorised into method, technology, end user and region. The method segment is fragmented into immunodiagnostics, molecular diagnostics and point of care diagnostics. The point of care testing market held the largest pneumococcal testing market share during the forecast period as this method can test multiple samples at once which provides efficient workflow for healthcare organizations. The technology segment is bifurcated into enzyme linked immunohistochemistry, immunofluorescence, polymerase chain reaction, western block and others. The end user segment is classified into hospital, diagnostic laboratories, homecare and others. The hospital segment is anticipated to lead the market owing to a rise in the number of patients diagnosed with pneumococcal symptoms with the ongoing COVID-19 pandemic.

Regional Analysis:

The North America region is predicted to dominate the market during the forecast period owing to a strong presence of key market players in the region, growing investments for research and development in pneumococcal testing methodologies. The Asia Pacific region, on the other hand, is expected to lead the market owing to increased demand for these tests with the rising geriatric population in countries like Japan, China.

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global Pneumococcal Testing Market By Method, By Technology, By End User and By Region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1 . Years Considered for the Study
  3.2 . Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1 . Secondary Data
  1.1.1 . Key Data from Secondary Sources
  1.2 . Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework on Country Level
  6.1 . Reimbursement Framework
  6.2 . Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Neurorehabilitation Devices Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Market Analysis tools
- 1. Industry Analysis - Porter’s
  1.1 . Supplier Power
  1.2 . Buyer Power
  1.3 . Substitution Threat
  1.4 . Threat from new entrants
  1.5 . Competitive Rivalry
  2. Pestel Analysis
  2.1 . Political Landscape
  2.2 . Environmental Landscape
  2.3 . Social landscape
  2.4 . Technology landscape
  2.5 . Legal Landscape
7. Pneumococcal Testing Market, By Method Historical Analysis and Forecast 2023-2031 (USD million)
- 1. Immunodiagnostics
  2. Molecular Diagnostics
  3. Point of Care Testing
8. Pneumococcal Testing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD million)
- 1. Enzyme Linked Immunosorbent Assay
  2. Immunofluorescence
  3. Western Blot
  4. Polymerase Chain Reaction
  5. Immunohistochemistry
  6. Others
9. Pneumococcal Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD million)
- 1. Hospitals
  2. Homecare
  3. Diagnostic Laboratories
  4. Others
10. North America Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
  2.1. U.S.
  2.2. Canada
  2.3. Mexico
  2.4 . Rest of North America
  3. Market Size (USD Mn) Forecast for North America 2023-2031
11. Latin America Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Regional Market Trends
  3. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
  3.1. Brazil
  3.2. Uruguay
  3.3 . Argentina
  3.4. Rest of Latin America
  4. Market Size (US$ Mn) Forecast for Latin America 2023-2031
12. Europe Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (US$ Mn) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5 . Switzerland
  2.6. Spain
  2.7. Russia
  2.8. Poland
  2.9. Rest of Western Europe
  3. Market Size (US$ Mn) Forecast for Europe 2023-2031
13. Asia Pacific Pneumococcal Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. Singapore
  2.4. Korea
  2.5. India
  2.6. Australia and New Zealand
  2.7. ASEAN
  2.8. Rest of Asia Pacific
  3. Market Size (US$ Mn) Forecast for Asia Pacific 2023-2031
14. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Mn) Analysis By Country, 2017-2022
  2.1. UAE
  2.2. South Africa
  2.3. Egypt
  2.4. Saudi Arabia
  2.5. Rest of MEA
  3. Market Size (US$ Mn) Forecast for MEA 2023-2031
15. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
- 1. Thermo Fisher Scientific Inc.
  1.1. Company Overview (HQ, Business Segments, Employee Strength)
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Abbott Laboratories
  2.1. Company Overview (HQ, Business Segments, Employee Strength)
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. F-Hoffmann la Roche Ltd.
  3.1. Company Overview (HQ, Business Segments, Employee Strength)
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Hologic Inc.
  4.1. Company Overview (HQ, Business Segments, Employee Strength)
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. bioMerieux
  5.1. Company Overview (HQ, Business Segments, Employee Strength)
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Becton Dickenson and Company
  6.1. Company Overview (HQ, Business Segments, Employee Strength)
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Bio-Rad Laboratories Inc.
  7.1. Company Overview (HQ, Business Segments, Employee Strength)
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Meridian Biosciences
  8.1. Company Overview (HQ, Business Segments, Employee Strength)
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Quest Diagnostics
  9.1. Company Overview (HQ, Business Segments, Employee Strength)
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Quidel
  10.1. Company Overview (HQ, Business Segments, Employee Strength)
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
17. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by
  administrations
  5. The overall economic slowdown of the developing and developed nations
18. Competitive Intelligence and Competitive Matrix
- 1. Competitive Intelligence
  2. Competitive Matrix
19. Major Deals and Strategic Alliances Analysis
- 1. Joint ventures
  2. Mergers and acquisitions
  3. Licensing and partnerships
  4. Technology Collaborations
  5. Strategic Divestments
  6. Market Entry Strategies
20. Relevant Case Studies and Latest News Updates
21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients